| abstract |
The present invention relates to respiratory disorders, sleep-related respiratory disorders, central and obstructive sleep apnea, upper airway resistance syndrome, chain-Stokes respiration, snoring, interrupted central respiratory tract, pediatric sudden death, postoperative hypoxia and Apnea, muscle-related respiratory disorders, respiratory disorders after prolonged gout, respiratory disorders during high altitude adaptation, acute and chronic lung disorders with hypoxia and hypercapnia, neurodegenerative disorders, dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, cancer disorders, A use of a Kv1.5 inhibitor for the manufacture of a medicament for the treatment or prophylaxis of breast cancer, lung cancer, colon cancer and prostate cancer.n n n Kv1.5 Inhibitor, TASK Potassium Channel, TASK-1, TASK-3, Respiratory Disorder |